0 items USD 0.00Search
Your search for "globaldata biostar pharmaceuticals inc bspm pharmaceuticals healthcare deals alliances profile" gave back 1456157 results.
Pharmaceutical Deal Trends (2010–2015) and In-Depth Analysis of Recent Deal Activity Summary GBI Research’s latest report, "Pharmaceutical Deal...
CBR Pharma Insights
October 2015
Price: USD 2,995.00
Esophageal Cancer - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
September 2018
Price: USD 2,000.00
Esophageal Cancer - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
March 2018
Price: USD 2,000.00
Hepatitis B - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis B...
Catalog:
Global Markets Direct
May 2018
Price: USD 2,000.00
Esophageal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's...
Catalog:
Global Markets Direct
June 2022
Price: USD 2,500.00
The global Microtubule Inhibitor Chemotherapy Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during...
Catalog:
GIR
July 2023
Price: USD 4,480.00
Microtubule inhibitor chemotherapy drugs are a class of anti-tumor chemotherapy drugs, which can inhibit tumor proliferation by inhibiting cell...
Catalog:
MRRPB5
July 2023
Price: USD 2,900.00
Highlights The global Targeted Drugs for Breast Cancer market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The global Microtubule Inhibitor Chemotherapy Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected...
Catalog:
LPI
July 2023
Price: USD 3,660.00
Highlights The global Tubulin Inhibitors for Breast Cancer market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The global Microtubule Inhibitor Chemotherapy Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million...
Catalog:
GIR
July 2023
Price: USD 3,480.00
The “Targeted Drugs for Breast Cancer Industry Forecast” looks at past sales and reviews total world Targeted Drugs for Breast Cancer sales in 2022,...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The “Tubulin Inhibitors for Breast Cancer Industry Forecast” looks at past sales and reviews total world Tubulin Inhibitors for Breast Cancer sales...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Market Analysis and Insights: Global Targeted Drugs for Breast Cancer Market The global Targeted Drugs for Breast Cancer market is projected to grow...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Market Analysis and Insights: Global Tubulin Inhibitors for Breast Cancer Market The global Tubulin Inhibitors for Breast Cancer market is projected...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Filter By Report Date
Filter By Industry
Filter By Country
- (-) Remove Global filter Global
- Latin America (4) Apply Latin America filter
- Middle East (3) Apply Middle East filter
- Africa (2) Apply Africa filter
- America (1) Apply America filter
- Americas (1) Apply Americas filter
- Asia (1) Apply Asia filter
- BRIC (1) Apply BRIC filter
- Caribbean (1) Apply Caribbean filter
- Oceania (1) Apply Oceania filter
